POLTEKKES KEMENKES III JAKARTA

bioMerieux Customer: Laboratory Report Printed Jul 5, 2022 16:29 ICT

System #: 14216 Printed by: LabAdmin

Patient Name: 20.1.ms Patient ID: 23

Isolate Group: 23-1

Card Type: GP Testing Instrument: 0000175A8885 (14216)

Card Type: AST-GP67 Testing Instrument: 0000175A8885 (14216)

Bionumber: 050402062763231

Comments:

Lot Sep 5, 2023 12:00

Card: GP 2422109103 Expires:
Identification Number: ICT
Information Jul 1, 2022 14:17 Analysis
Completed: Status: Final 4.00 hours
ICT Time:
99% Probability Staphylococcus aureus
Selected Organism Excellent
Bionumber: 050402062763231 Confidence:
identification
SRF
Organism
Analysis Organisms and Tests to Separate:

Analysis Messages:
The following antibiotic(s) are not claimed:
Ampicillin, Gentamicin High Level (synergy), Streptomycin High Level (synergy),

Contraindicating Typical Biopattern(s)

Installed VITEK 2 Systems Version: 07.01

MIC Interpretation Guideline: Global CLSI-based 2017 Therapeutic Interpretation Guideline: NATURAL RESISTANCE
AES Parameter Set Name: Global CLSI(2017)-based+Natural Resistance AES Parameter Last Modified: May 14, 2018
13:30 ICT

Page 1 of 2
 POLTEKKES KEMENKES III JAKARTA

bioMerieux Customer: Laboratory Report Printed Jul 5, 2022 16:29 ICT

System #: 14216 Printed by: LabAdmin

Patient Name: 20.1.ms Patient ID: 23

Isolate Group: 23-1

Card Type: GP Testing Instrument: 0000175A8885 (14216)

Card Type: AST-GP67 Testing Instrument: 0000175A8885 (14216)

Bionumber: 050402062763231

May 12, 2023

Card: AST-GP67 Lot Number: 1321993103 Expires:
12:00 ICT
Susceptibility Information Jul 1, 2022 Analysis
Completed: Status: Final 8.00 hours
18:17 ICT Time:
Antimicrobial MIC Interpretation Antimicrobial MIC Interpretation
Cefoxitin Screen NEG - Erythromycin >= 8 R
Benzylpenicillin >= 0.5 R Clindamycin >= 8 R
Ampicillin Quinupristin/Dalfopristin <= 0.25 S
Oxacillin 0.5 S Linezolid 2 S
Gentamicin High Level (synergy) Vancomycin 1 S
Streptomycin High Level (synergy) Tetracycline >= 16 R
Gentamicin <= 0.5 S Tigecycline 0.25 S
Ciprofloxacin <= 0.5 S Nitrofurantoin <= 16 S
Levofloxacin 0.25 S Rifampicin <= 0.5 S
Moxifloxacin <= 0.25 S Trimethoprim/Sulfamethoxazole <= 10 S
Inducible Clindamycin Resistance NEG -
+= Deduced drug *= AES modified **= User modified

Global
AES Findings: Last Modified: May 14, 2018 13:30 ICT Parameter Set: CLSI(2017)-based+Natu
ral Resistance
Confidence Level: Consistent

Installed VITEK 2 Systems Version: 07.01

MIC Interpretation Guideline: Global CLSI-based 2017 Therapeutic Interpretation Guideline: NATURAL RESISTANCE
AES Parameter Set Name: Global CLSI(2017)-based+Natural Resistance AES Parameter Last Modified: May 14, 2018
13:30 ICT

Page 2 of 2